10 A and B, respectively, and revealed an increasing trend in the mortality rate with increasing risk score.
← all excerpts
SLC8A1, a novel prognostic biomarker and immunotherapy target in RSA and UCEC based on scRNA-seq and pan-cancer analysis.
1
—
—